FDA Adverse Event Malfunction Summary report: N

SAFECLINITUBES

MDR report key: 2546839 · Received April 20, 2012

Report

Report Number
3002807968-2012-00006
Event Type
Malfunction
Date Received
April 20, 2012
Date of Event
February 28, 2012
Report Date
March 27, 2012
Manufacturer
RADIOMETER MEDICAL APS.
Product Code
GIO
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ON THIS NEONATAL DEPARTMENT THEY HAVE HAD TWO DIFFERENT TYPES OF PLASTIC CAPILLARY TUBES, I.E. SAFECLINITUBES D941P-NA-240-85 X 3, PART NO. 942-891, AND SAFECLINITUBES D957P-70-100 X 1, PART NO. 942-892. THESE TWO TYPES OF PLASTIC CAPILLARIES WERE MIXED UP BY THE USERS (NURSES AND PHYSICIANS) WHEN BLOOD SAMPLE MEASUREMENTS HAVE BEEN PERFORMED. THEY HAVE USED THE CAPILLARY TYPE WHICH CONTAINS SODIUM HEPARIN WHEN THEY PERFORMED BLOOD SAMPLE MEASUREMENTS TO GET ELECTROLYTE RESULTS. THIS IS A USE ERROR. WE HAVE REVIEWED THE PACKAGE LABELING AND INSERT FOR THE SAFECLINITUBES (ATTACHED). BOTH THE PACKAGE AND THE INSERT STATES WHICH TYPE OF HEPARIN THE TUBES CONTAIN. FURTHERMORE THE ABL835 ANALYZER OPERATORS MANUAL CONTAINS THE FOLLOWING CAUTION (P. 1-5 'LIMITATIONS OF USE AND KNOWN INTERFERING SUBSTANCES,'): 'ANTICOAGULANTS THAT CONTAIN SODIUM SALTS WILL GIVE ERRONEOUSLY HIGH CNA+ RESULTS. SODIUM FLUORIDE WITH OR WITHOUT EDTA AND OXALATE (DI NA) INFLUENCE CGLU RESULTS. SODIUM FLUORIDE GIVES ERRONEOUSLY HIGH CNA+ AND LOW CCA2+, CGLU AND CLAC RESULTS. TRI SODIUM CITRATE INFLUENCES CNA+, CK+ AND CGLU RESULTS.'

Description of Event or Problem · 1

AN ABL835 ANALYZER REPORTED RESULTS OF BLOOD SAMPLE MEASUREMENTS OF NEONATAL PTS WITH AN INCREASED CA VALUE OF APP. 0, 3 MMOL/L HIGHER THAN EXPECTED WHEN MEASUREMENTS WERE PERFORMED ON CAPILLARY BLOOD SAMPLES USING RADIOMETER PLASTIC CAPILLARY TUBES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SAFECLINITUBES PLASTIC CAPILLARY TUBES GIO RADIOMETER MEDICAL APS. D941P-NA-240-85 X 3 DW 01

Patients

Seq Age Sex Outcome Treatment
1